Wilbanks Smith & Thomas Asset Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,381	Closed	-$240K	–	515
2021 Q4	$240K	Hold	5,381	–	–	0.01%	459
2021 Q3	$271K	Buy	+5,381	New	+$271K	0.01%	418
2018 Q4	–	Sell	-150	Closed	-$3K	–	585
2018 Q3	$3K	Buy	+150	New	+$3K	﹤0.01%	1321